Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Syphilis Testing Market, by Type
1.4.2 North America Syphilis Testing Market, by Location of Testing
1.4.3 North America Syphilis Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Syphilis Testing Market by Type
3.1 North America Primary & Secondary Syphilis Market by Country
3.2 North America Others Market by Country
Chapter 4. North America Syphilis Testing Market by Location of Testing
4.1 North America Laboratory testing Market by Country
4.2 North America Point of care (POC) testing Market by Country
Chapter 5. North America Syphilis Testing Market by Country
5.1 US Syphilis Testing Market
5.1.1 US Syphilis Testing Market by Type
5.1.2 US Syphilis Testing Market by Location of Testing
5.2 Canada Syphilis Testing Market
5.2.1 Canada Syphilis Testing Market by Type
5.2.2 Canada Syphilis Testing Market by Location of Testing
5.3 Mexico Syphilis Testing Market
5.3.1 Mexico Syphilis Testing Market by Type
5.3.2 Mexico Syphilis Testing Market by Location of Testing
5.4 Rest of North America Syphilis Testing Market
5.4.1 Rest of North America Syphilis Testing Market by Type
5.4.2 Rest of North America Syphilis Testing Market by Location of Testing
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Danaher Corporation (Cepheid)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Becton, Dickinson and Company
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Thermo Fisher Scientific, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Bio-Rad laboratories, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expenses
6.6 Hologic, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent Strategies and Developments:
6.6.5.1 Approvals and Trials:
6.7 DiaSorin S.p.A. (Luminex Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent Strategies and Developments:
6.8.5.1 Approvals and Trials:
6.9 Siemens Healthineers AG (Siemens AG)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
Unique Offerings 